Literature DB >> 23436936

1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages.

Yunzi Chen1, Weicheng Liu, Tao Sun, Yong Huang, Youli Wang, Dilip K Deb, Dosuk Yoon, Juan Kong, Ravi Thadhani, Yan Chun Li.   

Abstract

The negative feedback mechanism is essential to maintain effective immunity and tissue homeostasis. 1,25-dihydroxyvitamin D (1,25[OH]2D3) modulates innate immune response, but the mechanism remains poorly understood. In this article, we report that vitamin D receptor signaling attenuates TLR-mediated inflammation by enhancing the negative feedback inhibition. Vitamin D receptor inactivation leads to hyperinflammatory response in mice and macrophage cultures when challenged with LPS, because of microRNA-155 (miR-155) overproduction that excessively suppresses suppressor of cytokine signaling 1, a key regulator that enhances the negative feedback loop. Deletion of miR-155 attenuates vitamin D suppression of LPS-induced inflammation, confirming that 1,25(OH)2D3 stimulates suppressor of cytokine signaling 1 by downregulating miR-155. 1,25(OH)2D3 downregulates bic transcription by inhibiting NF-κB activation, which is mediated by a κB cis-DNA element located within the first intron of the bic gene. Together, these data identify a novel regulatory mechanism for vitamin D to control innate immunity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23436936      PMCID: PMC3608760          DOI: 10.4049/jimmunol.1203273

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA.

Authors:  W Tam
Journal:  Gene       Date:  2001-08-22       Impact factor: 3.688

2.  T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC.

Authors:  Deanna Haasch; Yung-Wu Chen; Regina M Reilly; X Grace Chiou; Sandra Koterski; Morey L Smith; Paul Kroeger; Kerri McWeeny; Donald N Halbert; Karl W Mollison; Stevan W Djuric; James M Trevillyan
Journal:  Cell Immunol       Date:  2002 May-Jun       Impact factor: 4.868

3.  SOCS-1 participates in negative regulation of LPS responses.

Authors:  Reiko Nakagawa; Tetsuji Naka; Hiroko Tsutsui; Minoru Fujimoto; Akihiro Kimura; Tatsuo Abe; Ekihiro Seki; Shintaro Sato; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira; Koichi Yamanishi; Ichirou Kawase; Kenji Nakanishi; Tadamitsu Kishimoto
Journal:  Immunity       Date:  2002-11       Impact factor: 31.745

Review 4.  Suppressors of cytokine signalling (SOCS) in the immune system.

Authors:  Warren S Alexander
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

Review 5.  Epidemiology of inflammatory bowel disease.

Authors:  Edward V Loftus; William J Sandborn
Journal:  Gastroenterol Clin North Am       Date:  2002-03       Impact factor: 3.806

6.  Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88.

Authors:  Sophie Janssens; Kim Burns; Jurg Tschopp; Rudi Beyaert
Journal:  Curr Biol       Date:  2002-03-19       Impact factor: 10.834

7.  SOCS1/JAB is a negative regulator of LPS-induced macrophage activation.

Authors:  Ichiko Kinjyo; Toshikatsu Hanada; Kyoko Inagaki-Ohara; Hiroyuki Mori; Daisuke Aki; Masanobu Ohishi; Hiroki Yoshida; Masato Kubo; Akihiko Yoshimura
Journal:  Immunity       Date:  2002-11       Impact factor: 31.745

8.  Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism.

Authors:  Y C Li; M J Bolt; L P Cao; M D Sitrin
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-09       Impact factor: 4.310

9.  IRF3 mediates a TLR3/TLR4-specific antiviral gene program.

Authors:  Sean Doyle; Sagar Vaidya; Ryan O'Connell; Hajir Dadgostar; Paul Dempsey; Ting Wu; Govinda Rao; Ren Sun; Margaret Haberland; Robert Modlin; Genhong Cheng
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

10.  SOCS-1 protects against Chlamydia pneumoniae-induced lethal inflammation but hampers effective bacterial clearance.

Authors:  Tangbin Yang; Patrik Stark; Katrin Janik; Hans Wigzell; Martin E Rottenberg
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

View more
  78 in total

1.  Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype.

Authors:  Yasuo Kusunoki; Isao Matsui; Takayuki Hamano; Akihiro Shimomura; Daisuke Mori; Sayoko Yonemoto; Yoshitsugu Takabatake; Yoshiharu Tsubakihara; René St-Arnaud; Yoshitaka Isaka; Hiromi Rakugi
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

2.  CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D.

Authors:  H Bruns; M Böttcher; M Qorraj; M Fabri; S Jitschin; J Dindorf; L Busch; R Jitschin; A Mackensen; D Mougiakakos
Journal:  Leukemia       Date:  2016-12-23       Impact factor: 11.528

Review 3.  MicroRNA-155: a Novel Armamentarium Against Inflammatory Diseases.

Authors:  Wu Xiaoyan; Eva Maria Arriero Pais; Li Lan; Chen Jingrui; Miao Lin; Patrick Asare Fordjour; Fan Guanwei
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

4.  Regulatory Mechanisms of Vitamin D3 on Production of Nitric Oxide and Pro-inflammatory Cytokines in Microglial BV-2 Cells.

Authors:  Yevgeny Aster T Dulla; Yuki Kurauchi; Akinori Hisatsune; Takahiro Seki; Koichi Shudo; Hiroshi Katsuki
Journal:  Neurochem Res       Date:  2016-07-11       Impact factor: 3.996

Review 5.  Role of MicroRNA Regulation in Obesity-Associated Breast Cancer: Nutritional Perspectives.

Authors:  Ravi Kasiappan; Dheeran Rajarajan
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

6.  Vitamin D3 inhibits TNFα-induced latent HIV reactivation in J-LAT cells.

Authors:  G Nunnari; P Fagone; F Lazzara; A Longo; D Cambria; G Di Stefano; M Palumbo; L Malaguarnera; Michelino Di Rosa
Journal:  Mol Cell Biochem       Date:  2016-06-13       Impact factor: 3.396

Review 7.  Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review.

Authors:  Krista M Reich; Richard N Fedorak; Karen Madsen; Karen I Kroeker
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

8.  1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway.

Authors:  Jie Du; Yunzi Chen; Yongyan Shi; Tianjing Liu; Yong Cao; Yue Tang; Xin Ge; Hongguang Nie; Changqing Zheng; Yan Chun Li
Journal:  Inflamm Bowel Dis       Date:  2015-11       Impact factor: 5.325

9.  Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein.

Authors:  Yunzi Chen; Jing Zhang; Xin Ge; Jie Du; Dilip K Deb; Yan Chun Li
Journal:  J Biol Chem       Date:  2013-05-13       Impact factor: 5.157

10.  The role of Ets2 transcription factor in the induction of microRNA-155 (miR-155) by lipopolysaccharide and its targeting by interleukin-10.

Authors:  Susan R Quinn; Niamh E Mangan; Brian E Caffrey; Michael P Gantier; Bryan R G Williams; Paul J Hertzog; Claire E McCoy; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.